Mini-BEAM regimen

WikiDoc Resources for Mini-BEAM regimen
Articles
Most recent articles on Mini-BEAM regimen Most cited articles on Mini-BEAM regimen Review articles on Mini-BEAM regimen Articles on Mini-BEAM regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Mini-BEAM regimen Images of Mini-BEAM regimen Photos of Mini-BEAM regimen Podcasts & MP3s on Mini-BEAM regimen Videos on Mini-BEAM regimen
Evidence Based Medicine
Cochrane Collaboration on Mini-BEAM regimen Bandolier on Mini-BEAM regimen TRIP on Mini-BEAM regimen
Clinical Trials
Ongoing Trials on Mini-BEAM regimen at Clinical Trials.gov Trial results on Mini-BEAM regimen Clinical Trials on Mini-BEAM regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Mini-BEAM regimen NICE Guidance on Mini-BEAM regimen NHS PRODIGY Guidance FDA on Mini-BEAM regimen CDC on Mini-BEAM regimen
Books
Books on Mini-BEAM regimen
News
Mini-BEAM regimen in the news Be alerted to news on Mini-BEAM regimen News trends on Mini-BEAM regimen
Commentary
Blogs on Mini-BEAM regimen
Definitions
Definitions of Mini-BEAM regimen
Patient Resources / Community
Patient resources on Mini-BEAM regimen Discussion groups on Mini-BEAM regimen Patient Handouts on Mini-BEAM regimen Directions to Hospitals Treating Mini-BEAM regimen Risk calculators and risk factors for Mini-BEAM regimen
Healthcare Provider Resources
Symptoms of Mini-BEAM regimen Causes & Risk Factors for Mini-BEAM regimen Diagnostic studies for Mini-BEAM regimen Treatment of Mini-BEAM regimen
Continuing Medical Education (CME)
CME Programs on Mini-BEAM regimen
International
Mini-BEAM regimen en Espanol Mini-BEAM regimen en Francais
Business
Mini-BEAM regimen in the Marketplace Patents on Mini-BEAM regimen
Experimental / Informatics
List of terms related to Mini-BEAM regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: BCNU-Etoposide-AraC-Melphalan Regimen; Mini-BEAM Regimen

Overview

Mini-BEAM regimen refers to a dose-reduced variant of the BEAM conditioning regimen used in the transplant setting, consisting of carmustine (bis-chloroethylnitrosourea, BCNU), etoposide, cytarabine (AraC), and melphalan and used for the treatment of relapsed or refractory Hodgkin's lymphoma.

Regimen

BCarmustine (BCNU)

EEtoposide

ACytarabine (AraC)

MMelphalan

Indications

• Relapsed or refractory Hodgkin's lymphoma